BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piccoli SP. The FDA/critical path initiative/Duke-Margolis center for health policy public workshop on analytical validation of assays for biomarker qualification: an update on the White Paper. Bioanalysis 2018;10:893-6. [DOI: 10.4155/bio-2018-0125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Kar S, Paglialunga S, Jaycox SH, Islam R, Paredes AH. Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis. PLoS One 2019;14:e0217263. [PMID: 31291245 DOI: 10.1371/journal.pone.0217263] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
2 Lowes S, Brown M. Bioanalytical method validation guidance language and a decade of progress. Bioanalysis 2019;11:587-93. [DOI: 10.4155/bio-2019-0051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Piccoli SP, Garofolo F. Biomarker assay validation. Bioanalysis 2018;10:889-91. [DOI: 10.4155/bio-2018-0127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]